Amanda R. Graveline

Amanda R. Graveline

Auto-generated profile, based on publicly available information

Amanda R. Graveline

Wyss Institute for Biologically Inspired Engineering, Harvard University, Boston, MA 02115, USA

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 March 2018 in Nature Materials
Verified
Journal Article
Closed access
PDF file
ALAileen Weiwei Li
Aileen Weiwei Li
MSMiguel C. Sobral
Miguel C. Sobral
SBSoumya Badrinath
Soumya Badrinath
YCYoungjin Choi
Youngjin Choi
AGAmanda Graveline
Amanda Graveline
DMDavid J. Mooney
David J. Mooney

31 August 2018 in Science
Verified
Journal Article
Closed access
PDF file
RKReza Kalhor
Reza Kalhor
KKKian Kalhor
Kian Kalhor
LMLeo Mejia
Leo Mejia
KLKathleen Leeper
Kathleen Leeper
AGAmanda Graveline
Amanda Graveline
GCGeorge Church
George Church
Lineage tracing in mouse using CRISPR: A homing guide RNA (hgRNA) that directs CRISPR-Cas9 to its own DNA locus can diversify its sequence and act as an expressed genetic barcode. Kalhor et al. engineered a mouse line carrying 60 independent loci of hgRNAs, thus generating a large number of unique barcodes in various embryonic and extraembryonic tissues in fully developed mice. This method demonstrates lineage tracing from the very first branches of the development tree up to organogenesis events and was used to elucidate embryonic brain patterning. Science , this issue p. eaat9804

14 September 2014 in Nature Medicine
Verified
Journal Article
Closed access
PDF file
JKJoo H Kang
Joo H Kang
MSMichael Super
Michael Super
CYChong Wing Yung
Chong Wing Yung
RCRyan M Cooper
Ryan M Cooper
KDKarel Domansky
Karel Domansky
DIDonald E Ingber
Donald E Ingber

5 January 2017 in Advanced Biosystems
Verified
Journal Article
Closed access
PDF file
SKSandeep T. Koshy
Sandeep T. Koshy
ACAlexander S. Cheung
Alexander S. Cheung
LGLuo Gu
Luo Gu
AGAmanda R. Graveline
Amanda R. Graveline
DMDavid J. Mooney
David J. Mooney

10 February 2021 in Science Translational Medicine
Verified
Journal Article
Closed access
PDF file
YCYing Kai Chan
Ying Kai Chan
SWSean K. Wang
Sean K. Wang
CCColin J. Chu
Colin J. Chu
DCDavid A. Copland
David A. Copland
ALAlexander J. Letizia
Alexander J. Letizia
GCGeorge Church
George Church
Incorporating TLR9-inhibitory sequences in the AAV vector genome inhibits immunogenicity and enhances transgene expression in multiple animal models.

6 January 2016 in Nature Communications
Verified
Journal Article
Open access
AJAbhishek Jain
Abhishek Jain
AGAmanda Graveline
Amanda Graveline
AWAnna Wayerhouse
Anna Wayerhouse
AVAndyna Vernet
Andyna Vernet
RFRobert Flaumenhaft
Robert Flaumenhaft
DIDonald E Ingber
Donald E Ingber
Accurate assessment of blood haemostasis is essential for the management of patients who use extracorporeal devices, receive anticoagulation therapy or experience coagulopathies. However, current monitoring devices do not measure effects of haemodynamic forces that contribute significantly to platelet function and thrombus formation. Here we describe a microfluidic device that mimics a network of stenosed arteriolar vessels, permitting evaluation of blood clotting within small sample volumes under pathophysiological flow. By applying a clotting time analysis based on a phenomenological mathematical model of thrombus formation, coagulation and platelet function can be accurately measured in vitro in patient blood samples. When the device is integrated into an extracorporeal circuit in pig endotoxemia or heparin therapy models, it produces real-time readouts of alterations in coagulation ex vivo that are more reliable than standard clotting assays. Thus, this disposable device may be useful for personalized diagnostics and for real-time surveillance of antithrombotic therapy in clinic.